|
Deborah J. Neff is the President and Chief Executive Officer of Pathwork Diagnostics Inc. (formerly Predicant Biosciences Inc. and Biospect Inc.) which she joined in 2003. Pathwork is focused on applying genomics to unmet clinical needs in oncology. Prior to joining Pathwork from 1988 to 2003 Ms. Neff held a number of executive positions at Becton Dickinson and Company a $4 billion global medical technology and device company. Most recently from 2000 to 2003 she was Worldwide President of Becton Dickinson Biosciences and from 1995 to 2000 she was President of the Biosciences and Microbiology Systems as well as the Becton Dickinson Immunocytometry Systems. Before joining Becton Dickinson Ms. Neff held senior management positions with Organon-Teknicka Corporation and CooperBiomedical. In addition to serving on the Board of Predicant Ms. Neff is a member of the Advisory Board of the Healthcare Businesswomen's Association and a member of the Board of Directors of ForteBio a private life science company. Ms. Neff joined our board of directors in July 2003. | 